Session Overview

The development of improved, innovative models for the detection of toxicity of drugs, chemicals, or chemicals in cosmetics is crucial to efficiently bring new products safely to market in a cost-effective and timely manner. In addition, improvement in models to detect toxicity may reduce the incidence of unexpected post-marketing toxicity and reduce or eliminate the need for animal testing.This session welcomes speakers looking to address this need with their research

Session Chair: Dr Phil Jeffrey

Honorary Professor

William Harvey Research Institute, Queen Mary University of London


Keynote Speaker: Dr Lorna Ewart

Head of Microphysiological Systems Centre of Excellence, Innovative Medicines at AstraZeneca



The Presenters


Dr Parveen Sharma

Principal Investigator

University of Liverpool

My research focuses on cardiac and liver disease with a specialised interest into drug induced toxicity. The long term aim is to gain a greater understanding of the cellular mechanisms that result in disease, emphasising on key mechanisms and pathways of disease in order to identify clinically relevant therapeutic targets and early detection biomarkers. We have a specialised focus on membrane protein physiology, cellular toxicity and the development of 3D cell culture models that emulate more in vivo like structures.

To be confirmed

Call for Papers